Ah, the conclusion to the much ado hype about the spinoff of diagnostics. Merged in with another loser OTC company.
Agreed. I put this at a 90% failure rate, 10% success rate right now, and I'm not sure how a reverse split helps if they cannot get financing right now. Also, product release details have been sketchy.
I've wrote off my 6.5 million shares already at a loss. If it comes back, great, but I'm taking the loss on paper for now.
It's been irking me ever since VOIS stated "a marketing firm", but refused to name them. That should have been my sell on the tell.
Whether or not the reverse split will bring on investors per the last PR. This doesn't look too good. They claim sales, but I'm skeptical, especially since I got destroyed on this investment. So we will know if they are 100% full of garbage if after the reverse split, they get no investors.
This P.R. was more of, "Wait until next year after more marketing". Which is not good. And the market reaction was a thud. I'll accept the beating I took on this one.
Interesting to hear. It's sounding like I'll be taking a loss against my initial gains on this.
As somebody who is long 6.5 million shares, I agree, this is bad. If no PR is release quick, this thing may go to no bid.
The price drop is unfortunate. I'm averaged in at 0.002. The company needs to release sales and marketing progress, otherwise this thing is going to tank hard.
I have a guestimate at 20% this advances and 80% it fails. I'm long 6.5 million shares, so this hurts to watch.